New 'innovation fund' between UT Southwestern and Taysha Gene Therapies

Updated: Apr 24, 2021

Taysha Gene Therapies is a company based in Dallas and is focused on drug development and commercialization. They have joined forces with UT Southwestern, where they will launch an innovation fund that will be used exclusively for funding research at UT Southwestern’s Gene Therapy Program and developing new gene therapies.

President, founder and CEO of Taysha, RA Sessions II, said, "We are pleased by the significant progress our parternship has achieved and are excited to build on that foundation and momentum to bring additional compelling innovation to the clinic."